Tyson Aschliman, Chief Operating Officer of Neway Dialysis Labs, pictured in a company shirt.

Tyson Aschliman

Chief Operating Officer

I started my career in manufacturing management where I developed as a value stream-focused operator. In 2016, I left manufacturing to join the world of ESRD and dialysis as a program CEO. I did this so that I could have an impact on patient lives. In dialysis, I have a sense of purpose, because we are saving lives and providing better quality of life for people who have been dealt an unfortunate path with an ESRD diagnoses.  As a dialysis organization CEO, I know first-hand the challenges facing ESRD providers. Rising costs are far outpacing increases in reimbursement rates so it is critical that the ESRD community finds new ways to drive better patient care while reducing costs. I joined Neway as a co-founder and Chief Operating Officer because we equip dialysis providers with a revolutionary service that allows better patient care with a greater efficiency and better overall value. It's about time that Providers have this kind of opportunity regarding ESRD lab services. That's my Neway story.